| Nemtabrutinib |
ARQ-531; MK-1026 |
Phase 3 Clinical |
Arqule Inc |
Hematologic Neoplasms; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Follicular; Richter's Syndrome; Hepatic Insufficiency; Waldenstrom Macroglobulinemia; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
| Fenebrutinib |
G-0853; RG-7845; GDC-0853; RO-7010939 |
Phase 3 Clinical |
Genentech Inc |
Arthritis, Rheumatoid; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Lupus Erythematosus, Systemic; Urticaria; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
| Remibrutinib |
LOU-064; LOU064-NXA; NVP-LOU064-NXA |
Phase 3 Clinical |
Novartis Pharma Ag |
Multiple Sclerosis, Relapsing-Remitting; Myasthenia Gravis; Chronic Urticaria; Sjogren's Syndrome; Multiple Sclerosis; Dermatitis; Urticaria; Asthma; Hepatic Insufficiency; Sjogren-Larsson Syndrome; Peanut Hypersensitivity; Hidradenitis Suppurativa; Disease Susceptibility |
Details
|
| Larotinib Mesylate |
Z-650 |
Phase 3 Clinical |
Guangdong Dongyangguang Pharmaceutical Co Ltd |
Solid tumours; Esophageal Neoplasms; Pancreatic Neoplasms; Esophageal Squamous Cell Carcinoma |
Details
|
| Tolebrutinib |
PRN-2246; SAR-442168 |
Phase 3 Clinical |
Principia Biopharma Inc |
Myasthenia Gravis; Renal Insufficiency; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis; Hepatic Insufficiency |
Details
|
| Abivertinib |
A-610MA; AC-0010; AC-0100; AC-001; AC-0010MA; AC-0100-Maleate; EX-ACEA0010MA |
Phase 3 Clinical |
Zhejiang Acea Pharmaceutical Co Ltd, Hangzhou Acea Pharmaceutical Research Co Ltd |
Lymphoma, B-Cell; Coronavirus Disease 2019 (COVID-19); Lymphoma, Large B-Cell, Diffuse; Prostatic Neoplasms; Lymphoma, Mantle-Cell; Lymphoma; Lymphoma, Non-Hodgkin; Carcinoma, Non-Small-Cell Lung; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
| Atuzabrutinib |
PRN-473; SAR-444727 |
Phase 2 Clinical |
Principia Biopharma Inc, Sanofi |
Dermatitis, Atopic |
Details
|
| Elsubrutinib/Upadacitinib |
ABBV-599 |
Phase 2 Clinical |
Abbvie Inc |
Arthritis, Rheumatoid; Lupus Erythematosus, Systemic |
Details
|
| Poseltinib |
HM-71224; LY3337641; NB-02 |
Phase 2 Clinical |
Hanmi Pharmaceutical Co Ltd |
Arthritis, Rheumatoid; Lymphoma, Large B-Cell, Diffuse; Central Nervous System Lymphoma; Primary vitreoretinal lymphoma |
Details
|
| TAS-5315 |
TAS-5315 |
Phase 2 Clinical |
Taiho Pharmaceutical Co Ltd |
Chronic Urticaria; Arthritis, Rheumatoid |
Details
|
| HZ-A-018 |
HZ-A-018 |
Phase 2 Clinical |
Hangzhou Yuzheng Pharmaceutical Technology Co Ltd, HeaZen Therapeutics Co Ltd |
Lymphoma, B-Cell; Multiple Sclerosis; Neuromyelitis Optica; Thrombocytopenia; Central Nervous System Lymphoma |
Details
|
| Branebrutinib |
BMS-986195 |
Phase 2 Clinical |
Bristol-Myers Squibb Company |
Arthritis, Rheumatoid; Sjogren's Syndrome; Immune System Diseases; Lupus Erythematosus, Systemic; Dermatitis, Atopic |
Details
|
| BIIB-091 |
BIIB-091 |
Phase 2 Clinical |
Biogen Inc |
Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis |
Details
|
| WXFL10230486 |
WXFL-10230486; WX-486; HWH-486 |
Phase 2 Clinical |
Wuxi Apptec Co Ltd, Humanwell Healthcare (Group) Co Ltd |
Chronic Urticaria; Arthritis, Rheumatoid |
Details
|
| M-7583 |
M7583; M-7583 |
Phase 2 Clinical |
Merck & Co Inc |
Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
| Edralbrutinib |
TG-1701; SHR-1459 |
Phase 2 Clinical |
Jiangsu Hengrui Medicine Co Ltd, Jiangsu shengdi Medicine Co Ltd |
Lymphoma, B-Cell; Nephrosis; Arthritis, Rheumatoid; Autoimmune Diseases; Glomerulonephritis, Membranous; Neuromyelitis Optica; Lymphoma; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
| TL-925 |
TL-925 |
Phase 2 Clinical |
Telios Pharmaceuticals |
Dry Eye Syndromes; Conjunctivitis, Allergic |
Details
|
| HBW-3210 |
HBW-3210; HBW3210 |
Phase 2 Clinical |
Chengdu Haibowei Pharmaceutical Co Ltd |
Lymphoma, B-Cell |
Details
|
| TQB-3702 |
TQB3702; TQB-3702 |
Phase 2 Clinical |
Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd |
Lymphoma, B-Cell; Hematologic Neoplasms; Neoplasms; Chronic Urticaria; Lupus Erythematosus, Systemic |
Details
|
| HBW-3220 |
HBW-3220; HBW-3-10; HBW-003 |
Phase 2 Clinical |
Chengdu Haibowei Pharmaceutical Co Ltd |
Lymphoma, B-Cell; Autoimmune Diseases; Lymphoma, Non-Hodgkin; Glomerulonephritis |
Details
|
| DZD-8586 |
DZD-8586 |
Phase 2 Clinical |
Dizal (Jiangsu) Pharmaceutical Co Ltd |
Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
| BGB-16673 |
BGB-16673; [14C]-BGB-16673 |
Phase 2 Clinical |
BeOne Medicines Ltd |
Lymphoma, B-Cell, Marginal Zone; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Lymphoma, Mantle-Cell; Lymphoma, Follicular; Leukemia, B-Cell; Lymphoma, Non-Hodgkin; Waldenstrom Macroglobulinemia; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
| HMPL-760 |
HMPL-760; HMPL760 |
Phase 2 Clinical |
Hutchison Medipharma Ltd |
Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Richter's Syndrome; Lymphoma, Follicular; Lymphoma; Lymphoma, Non-Hodgkin; Waldenstrom Macroglobulinemia; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
| Rocbrutinib |
LP-168; NWP-775 |
Phase 2 Clinical |
Newave Pharmaceutical Inc |
Lymphoma, B-Cell, Marginal Zone; Hematologic Neoplasms; Lymphoma, B-Cell; Leukemia, Hairy Cell; Neoplasms; Lymphoma, Large B-Cell, Diffuse; Multiple Sclerosis; Neuromyelitis Optica; Lymphoma, Mantle-Cell; Lymphoma, Follicular; Waldenstrom Macroglobulinemia; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
| MH-048 |
MH-048; MH048 |
Phase 2 Clinical |
Minghui Pharmaceutical (Shanghai) Co Ltd |
Lymphoma, B-Cell |
Details
|
| Elsubrutinib |
ABBV-105 |
Phase 2 Clinical |
Abbvie Ltd |
Arthritis, Rheumatoid; Lupus Erythematosus, Systemic |
Details
|
| CX-1440 |
CX1440; CX-1440 |
Phase 2 Clinical |
Hangzhou Sanyintai Pharmaceutical Technology Co Ltd, Hangzhou Aojin Biomedical Technology Co Ltd |
Lymphoma, B-Cell; Purpura, Thrombocytopenic, Idiopathic; Graft vs Host Disease; Multiple Sclerosis; Lupus Erythematosus, Systemic; Urticaria; Leukemia, B-Cell; Thrombocytopenia |
Details
|
| JNJ-64264681 |
JNJ-4681; JNJ-64264681 |
Phase 1 Clinical |
Johnson & Johnson |
Solid tumours; Hematologic Neoplasms; Neoplasms; Myelodysplastic Syndromes; Prostatic Neoplasms, Castration-Resistant; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
| PCI-45292 |
|
Phase 1 Clinical |
Pharmacyclics Llc |
Arthritis, Rheumatoid; Autoimmune Diseases |
Details
|
| BMS-935177 |
|
Phase 1 Clinical |
Bristol-Myers Squibb Company |
Immune System Diseases |
Details
|
| BT-1053 |
BT-1053 |
Phase 1 Clinical |
Chengdu Brilliant Pharmaceutical Co Ltd, ScinnoHub Pharmaceutical Co Ltd |
Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Follicular; Waldenstrom Macroglobulinemia; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
| BTK-Max |
BTK-Max |
Phase 1 Clinical |
Bristol-Myers Squibb Company |
Arthritis, Rheumatoid; Psoriasis |
Details
|
| DTRMWXHS-12 |
DTRMWXHS-12; DTRM-12 |
Phase 1 Clinical |
Zhejiang Dtrm Biopharma Co Ltd |
Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
| FCN-647 |
FCN-647 |
Phase 1 Clinical |
Fochon Pharmaceuticals Ltd |
Lymphoma, B-Cell; Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
| SN-1011 |
SN-1011 |
Phase 1 Clinical |
Sinomab Bioscience Ltd |
Lupus Erythematosus, Systemic |
Details
|
| AC-0058TA |
AC-0058; AC-0058TA |
Phase 1 Clinical |
Hangzhou Acea Pharmaceutical Research Co Ltd, Zhejiang Acea Pharmaceutical Co Ltd |
Arthritis, Rheumatoid; Lupus Erythematosus, Systemic |
Details
|
| BI-BTK-1 |
BI-BTK-1 |
Phase 1 Clinical |
C.H. Boehringer Sohn Ag & Co. Kg |
Lupus Nephritis |
Details
|
| DTRM-505 |
DTRM-505 |
Phase 1 Clinical |
|
Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
| DWP-212525 |
DWP-212525 |
Phase 1 Clinical |
Daewoong Pharmaceutical Co Ltd |
Autoimmune Diseases; Arthritis, Rheumatoid; Lupus Erythematosus, Systemic; Pemphigus |
Details
|
| DWP-213388 |
DWP-213388 |
Phase 1 Clinical |
Daewoong Pharmaceutical Co Ltd |
Autoimmune Diseases |
Details
|
| NX-5948 |
NX-5948 |
Phase 1 Clinical |
Nurix Therapeutics Inc |
Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Follicular; Waldenstrom Macroglobulinemia; Central Nervous System Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
| UBX-303061 |
UBX-303061 |
Phase 1 Clinical |
Ubix Therapeutics Inc |
Lymphoma, B-Cell |
Details
|
| [14C]Pirtobrutinib |
LOXO-305; [14C]RXC-005; RXC-005; [14C]LOXO-305 |
Phase 1 Clinical |
Redx Pharma Ltd |
|
Details
|
| ANG-0623 |
ANG-0623; ANG0623 |
Phase 1 Clinical |
Angel Pharmaceuticals Co Ltd |
Multiple Sclerosis |
Details
|
| XS-04 |
XS-04 |
Phase 1 Clinical |
Jiangsu Xingsheng Xinhui Pharmaceutical Co Ltd |
Hematologic Neoplasms; Lymphoma, Large B-Cell, Diffuse |
Details
|
| HZ-Q1070 |
HZ-Q1070; HZ-Q-1070 |
Phase 1 Clinical |
HeaZen Therapeutics Co Ltd |
Lymphoma, B-Cell; Neoplasms |
Details
|
| ABBV-101 |
ABBV-101 |
Phase 1 Clinical |
Abbvie Inc |
Hematologic Neoplasms |
Details
|
| IMG-004 |
IMG-004 |
Phase 1 Clinical |
Hutchmed (China) Ltd |
Chronic Urticaria |
Details
|
| XNW-1011 |
EVER001; EVER-001; XNW1011; XNW-1011; SN-1011; SN1011 |
Phase 1 Clinical |
Suzhou Sinovent Pharmaceuticals Co Ltd, Sinomab Bioscience Ltd |
Lymphoma, B-Cell; Autoimmune Diseases; Glomerulonephritis, Membranous; Multiple Sclerosis; Neuromyelitis Optica; Lupus Erythematosus, Systemic; Nephrotic Syndrome; Pemphigus |
Details
|
| AC-0676 |
AC0676; AC-676; AC676; AC-0676 |
Phase 1 Clinical |
Accutar Biotechnology Inc |
Hematologic Neoplasms; Lymphoma, B-Cell; Autoimmune Diseases |
Details
|
| JDB175 |
JDB175 |
Phase 1 Clinical |
Shanghai Jiabao Yaoyin Pharmaceutical Technology Co Ltd |
Lymphoma, Large B-Cell, Diffuse; Multiple Sclerosis |
Details
|
| SS-001 |
SS-001 |
Phase 1 Clinical |
Zibo Baijichangsheng Pharmaceutical Co Ltd |
Lymphoma, B-Cell |
Details
|
| BMS-986196 |
11C-BMS-986196 |
Phase 1 Clinical |
Bristol-Myers Squibb Company |
Multiple Sclerosis |
Details
|
| Docirbrutinib |
AS-1763; BN-102; CB-1763 |
Phase 1 Clinical |
Bionova Pharmaceuticals (Shanghai) Ltd, Carna Biosciences Inc |
Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Leukemia, B-Cell; Waldenstrom Macroglobulinemia; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
| Sofnobrutinib |
AS-0871; AS-871 |
Phase 1 Clinical |
Carna Biosciences Inc |
Autoimmune Diseases |
Details
|
| NX-2127 |
NX-2127 |
Phase 1 Clinical |
Nurix Therapeutics Inc |
Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Waldenstrom Macroglobulinemia; Leukemia, Lymphocytic, Chronic, B-Cell; Central Nervous System Lymphoma |
Details
|
| TT-01488 |
TT-01488 |
Phase 1 Clinical |
TransThera Sciences (Nanjing) Inc |
Lymphoma, B-Cell; Solid tumours; Leukemia, B-Cell |
Details
|
| SYHA-1811 |
SYHA-1811 |
Phase 1 Clinical |
Shanghai Runshi Pharmaceutical Technology Co Ltd |
Lymphoma, B-Cell |
Details
|
| HSK-29116 |
HSK-29116 |
Phase 1 Clinical |
Sichuan Haisco Pharmaceutical Co Ltd |
Lymphoma, B-Cell |
Details
|
| YZJ-3058 |
|
Phase 1 Clinical |
Shanghai Haiyan Pharmaceutical Technology Co Ltd |
Arthritis, Rheumatoid; Lymphoma, Large B-Cell, Diffuse; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
| ZXBT-1158 |
ZXBT-1158 |
Phase 1 Clinical |
Guangzhou BeBetter Medicine Technology Co |
Lymphoma, B-Cell; Multiple Sclerosis |
Details
|
| Luxeptinib |
CG026806; CG-806; CG’806; CG-026806 |
Phase 1 Clinical |
Crystalgenomics Inc |
Hematologic Neoplasms; Myelodysplastic Syndromes; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
| Evobrutinib |
M-2951; MSC-2364447; MSC-2364447-C; MSC2364447C |
Phase 1 Clinical |
Merck Serono |
Multiple Sclerosis, Relapsing-Remitting; Renal Insufficiency; Arthritis, Rheumatoid; Multiple Sclerosis; Lupus Erythematosus, Systemic; Hepatic Insufficiency |
Details
|
| GB-5121 |
GB-5121; GB5121 |
Clinical |
Gossamer Bio Inc |
Neurolymphomatosis; Central Nervous System Lymphoma |
Details
|
A-Z
